Reckless Push to Expand Mail-order Abortion Pills from Overseas Jeopardizes Women’s Health and Safety Washington, D.C. – Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List, released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration (FDA) enforcement of the regulation of dangerous abortion […]
Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex. The changes, announced on March 30, significantly increase the duration of pregnancy at which the drug regimen may be administered, raising it from 49 days (7 weeks) from the last menstrual period (LMP) to 70 days (10 weeks) post-LMP.
Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up to 70 days into pregnancy, three weeks past the previous guidelines. On the same day, Abby Johnson’s The Walls Are Talking: Former Abortion Clinic Workers Tell Their Stories, was officially released. One chapter in particular stood out as especially timely in regards to the news: “Medication Abortion.”